Skip to content
Intus Bio logo

Intus Bio Alternatives & Competitors

12 companies similar to Intus Bio — Revolutionary microbiome research, discovery & testing

Companies similar to Intus Bio

Design Pharmaceuticals Inc. logo — alternative to Intus Bio

Design Pharmaceuticals Inc.

Boundless GPCR drug discovery

BellBrook Labs logo — alternative to Intus Bio

BellBrook Labs

BellBrook Labs is dedicated to accelerating drug discovery and biological research.

Mainz Biomed logo — alternative to Intus Bio

Mainz Biomed

Saving lives through innovative molecular diagnostic solutions.

Yaqrit logo — alternative to Intus Bio

Yaqrit

The Liver Disease Company

Rival Readout

Competing with Intus Bio? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
StemoniX logo — alternative to Intus Bio

StemoniX

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

Yolife GmbH logo — alternative to Intus Bio

Yolife GmbH

Live longer in good health

BillionToOne logo — alternative to Intus Bio

BillionToOne

We push the boundaries of molecular diagnostics through quantitative technologies.

The National Institutes of Health logo — alternative to Intus Bio

The National Institutes of Health

Discover What's Next at the NIH

xRapid Group logo — alternative to Intus Bio

xRapid Group

Pushing the boundaries of Artificial Intelligence in diagnostics

Carenostics logo — alternative to Intus Bio

Carenostics

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease us...

Adarza BioSystems, Inc. logo — alternative to Intus Bio

Adarza BioSystems, Inc.

Adarza’s ZIVA technology platform enables highly multiplexed label-free detection of serum...

Cyted Health logo — alternative to Intus Bio

Cyted Health

Transforming access to digestive health for everyone, everywhere.

About Intus Bio

Intus Bio, established in 2015, is an innovative leader in the Biotechnology, Health Care, and Clean Energy sectors, headquartered in the United States. The company is pioneering advancements with its proprietary high-resolution, high-throughput assay and analysis technology, offering unmatched detail and accuracy in m...

Services

Microbiome Testing, Gut Health Optimization, Cancer Detection Tools, Chronic Disease Prevention Solutions

Target Customers

Healthcare Providers, Medical Researchers, Academic Institutions, Clinicians, Patients focused on gut health

Business keywords

Microbiome Research, High-resolution Assay, High-throughput Analysis, Bacterial Identification, Pharmaceutical Industry, Diagnostic Industry, Testing Industry, Health Applications, Agricultural Applications, Environmental Applications, Partnerships, Technology Development

Frequently Asked Questions

Companies similar to Intus Bio include Design Pharmaceuticals Inc., BellBrook Labs, Mainz Biomed, Yaqrit, StemoniX. They work in Biotechnology and Health Care and share Intus Bio's focus on pharmaceutical industry.
Bounce Watch lists 12 companies that share Intus Bio's industries and are closest to it in business tags, services, target customers, business model and size.
Intus Bio, established in 2015, is an innovative leader in the Biotechnology, Health Care, and Clean Energy sectors, headquartered in the United States. The company is pioneering advancements with its proprietary high-resolution, high-throughput assay and analysis technology, offering unmatched detail and accuracy in m...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Intus Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Intus Bio on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout